Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients

Journal of Vascular Surgery

Volumn 56, Issue 1, 2012, Pages 96-105

  Monaco, Mario ^a   Di Tommaso, Luigi ^b   Pinna, Giovanni Battista ^b   Lillo, Stefano ^a   Schiavone, Vincenzo ^a   Stassano, Paolo ^b  

^a Istituto Clinico Pineta Grande   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; FEMOROPOPLITEAL BYPASS; FOLLOW UP; GRAFT PATENCY; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL ARTERIAL ISCHEMIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ASPIRIN; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; LOGISTIC MODELS; MALE; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TICLOPIDINE; TREATMENT OUTCOME; VASCULAR PATENCY; WARFARIN;

EID: 84862985576     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.01.004     Document Type: Article

References (40)

1. L.P. Jensen, M. Lepäntalo, J.E. Fossdal, O.C. Roder, B.S. Jensen, M.S. Madsen Dacron or PTFE for above-knee femoropopliteal bypass A multicenter randomised study Eur J Vasc Endovasc Surg 34 2007 44 49
2. C.E. Pereira, M. Albers, M. Romiti, F.C. Brochado-Neto, C.A. Pereira Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency J Vasc Surg 44 2006 510 517
3. F. Sala, R. Hassen-Khodja, A. Lecis, P.J. Bouillanne, S. Declemy, M. Batt Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts Ann Vasc Surg 17 2003 401 407
4. M.J. Tangelder, J.A. Lawson, A. Algra, B.C. Eikelboom Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery J Vasc Surg 30 1999 701 709
5. E.C. Lipsitz, S. Kim Antithrombotic therapy in peripheral arterial disease Cardiol Clin 26 2008 289 298
6. Antiplatelet Trialists Collaborative overview of randomised trials of antiplatelet therapy-II: maintenance of vascular graft or arterial patency by antiplatelet therapy BMJ 308 1994 159 168
7. M.H. Criqui, R.D. Langer, A. Fronek, H.S. Feigelson, M.R. Klauber, T.J. McCann Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
8. G.C. Leng, A.J. Lee, F.G. Fowkes, M. Whiteman, J. Dunbar, E. Housley Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population Int J Epidemiol 25 1996 1172 1181
9. C. McCollum, C. Alexander, G. Kenchington, P.J. Franks, R.M. Greenhalgh Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial J Vasc Surg 13 1991 150 162
10. T.C. Collins, J. Souchek, R.J. Beyth Benefits of antithrombotic therapy after infrainguinal bypass grafting: a meta-analysis Am J Med 117 2004 93 99
11. J.G. Regensteiner, W.R. Hiatt Current medical therapies for patients with peripheral arterial disease: a critical review Am J Med 112 2002 49 57
12. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, J.L. Halperin Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions Society for Vascular Medicine and Biology, Society of Interventional Radiology and the ACC; 2005/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation J Am Coll Cardiol 47 2006 1239 1312.
13. R.S. Brumberg, M.R. Back, P.A. Armstrong, D. Cuthbertson, M.L. Shames, B.L. Johnson The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure J Vasc Surg 46 2007 1160 1166
14. WAVE Investigators The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials Am Heart J 151 2006 1 9
15. Warfarin Antiplatelet Vascular Evaluation Trial Investigators S. Anand, S. Yusuf, C. Xie, J. Pogue, J. Eikelboom, B. Sussex et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease N Engl J Med 357 2007 217 227
16. T.P. Sarac, T.S. Huber, M.R. Back, C.K. Ozaki, L.M. Carlton, T.C. Flynn Warfarin improves the outcome of femoropopliteal vein bypass grafting at high risk for failure J Vasc Surg 28 1998 446 457
17. Dutch Bypass Oral anticoagulants or Aspirin (BOA) Study Group Efficacy of oral anticoagulants compared with aspirin after femoropopliteal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial Lancet 355 2000 346 351
18. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) CAPRIE Steering Committee Lancet 348 1996 1329 1339
19. P.P. Cacoub, D.L. Bhatt, P.G. Steg, E.J. Topol, M.A. Creager CHARISMA Investigators Patients with peripheral arterial disease in the CHARISMA trial Eur Heart J 30 2009 192 201
20. R.R. Fares, L.S. Lansing, C.A. Gallati, S.A. Mousa Antiplatelet therapy with clopidogrel and aspirin in vascular diseases: clinical evidence for and against the combination Expert Opin Pharmacother 9 2008 377 386
21. G.A. Peterkin, S. Manabe, W.W. LaMorte, J.O. Menzoian Evaluation of a proposed standard reporting system for preoperative angiograms in infrainguinal bypass procedures: angiographic correlates of measured runoff resistance J Vasc Surg 7 1988 379 385
22. P.M. Ridker, S.Z. Goldhaber, E. Danielson, Y. Rosenberg, C.S. Eby, S.R. Deitcher Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism N Engl J Med 348 2003 1425 1434
23. V. Pengo, U. Cucchini, G. Denas, B.L. Davidson, F. Marzot, S.P. Jose Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation Thromb Haemost 103 2010 442 449
24. M. Torella, D. Torella, P. Chiodini, M. Franciulli, G. Romano, L. De Santo LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT." Trial Am Heart J 160 2010 171 178
25. K.H. Johansen, J.C. Watson Dacron femoral-popliteal bypass grafts in good-risk claudicant patients Am J Surg 187 2004 580 584
26. R.J. van Det, B.H. Vriens, J. van der Palen, R.H. Geelkerken Dacron or ePTFE for femoropopliteal above-knee bypass grafting: short- and long-term results of a multicentre randomised trial Eur J Vasc Endovasc Surg 37 2009 457 463
27. F.E. Harrell Jr Regression modeling strategies: with application to linear models, logistic regression, and survival analysis 2001 Springer-Verlag New York
28. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, E. Briët A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
29. G. Kretschmer, F. Herbst, M. Prager, T. Sautner, E. Wenzl, G.A. Berlakovich A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis Arch Surg 127 1992 1112 1115
30. B. Arfvidsson, F. Lundgren, C. Drott, T. Scherstén, K. Lundholm Influence of coumadin treatment on patency and limb salvage after peripheral arterial reconstructive surgery Am J Surg 159 1990 556 560
31. D. Rosenthal, M.J. Mittenthal, D.M. Ruben, D.H. Jones, J.W. Estes, P.E. Stanton The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results Am Surg 53 1987 477 481
32. M.R. Jackson, W.C. Johnson, W.O. Williford, R.J. Valentine, G.P. Clagett The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from a multicenter randomized clinical trial J Vasc Surg 35 2002 292 298
33. T.K. Liem, D. Silver Coumadin: principles of use Semin Vasc Surg 9 1996 354 361
34. M.J. Tangelder, A. Algra, J.A. Lawson, S. Hennekes, B.C. Eikelboom Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery Dutch BOA Study Group J Vasc Surg 33 2001 522 527
35. J. Karnon, A. Brennan, A. Pandor, G. Fowkes, A. Lee, D. Gray Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK Curr Med Res Opin 21 2005 101 112
36. M.D. Schleinitz, J.P. Weiss, D.K. Owens Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis Am J Med 116 2004 797 806
37. L. Jones, S. Griffin, S. Palmer, C. Main, V. Orton, M. Sculpher Psychological treatment for insomnia in the regulation of long-term hypnotic drug use Health Technol Assess 8 2004 1 196 iii-iv
38. C.L. Sudlow, G. Mason, J.B. Maurice, C.J. Wedderburn, G.J. Hankey Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients Cochrane Database Syst Rev 4 2009 CD001246
39. M.F. Caruana, A.W. Bradbury, D.J. Adam The validity, reliability, reproducibility and extended utility of ankle to brachial pressure index in current vascular surgical practice Eur J Vasc Endovasc Surg 29 2005 443 451
40. E.K. Hoogeveen, A.J. Mackaay, P.J. Beks, P.J. Kostense, J.M. Dekker, R.J. Heine Evaluation of the one-minute exercise test to detect peripheral arterial disease Eur J Clin Invest 38 2008 290 295